<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2023.112009</article-id><article-id pub-id-type="publisher-id">JBM-123109</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Implication of Oxidative Stress and Antioxidant Defence Systems in Symptomatic and Asymptomatic &lt;i&gt;Plasmodium falciparum&lt;/i&gt; Malaria Infection among Children Aged1 to 15 Years in the Mount Cameroon Area
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tambong</surname><given-names>Ako Ojongnkpot</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>David</surname><given-names>Denis Sofeu-Feugaing</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vanessa</surname><given-names>Tita Jugha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Germain</surname><given-names>Sotoing Taiwe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Helen</surname><given-names>Kuokuo Kimbi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Animal Biology and Conservation, Faculty of Science, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Department of Biomedical Sciences, Faculty of Health Sciences, The University of Bamenda, Bamenda, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>02</month><year>2023</year></pub-date><volume>11</volume><issue>02</issue><fpage>124</fpage><lpage>145</lpage><history><date date-type="received"><day>16,</day>	<month>December</month>	<year>2022</year></date><date date-type="rev-recd"><day>14,</day>	<month>February</month>	<year>2023</year>	</date><date date-type="accepted"><day>17,</day>	<month>February</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  It is known that the pathogenicity of Plasmodium induces the breakdown of haemoglobin, which leads to the induction of oxidative stress. This study aimed to identify the possible effects of oxidative stress and antioxidant defence systems in symptomatic and asymptomatic 
  <em>Plasmodium falciparum </em>malaria infection in children (1 - 15 years old) in the Mount Cameroon vicinity. This cross-sectional study involved blood samples collected from 473 children and examined for malaria parasitaemia. Full blood counts were performed using an automated haemoanalyser. Serum oxidative stress status (malondialdehyde (MDA), nitric oxide (NO), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD) and vitamin C (Vit C)) were each determined by colorimetric enzymatic assays. The prevalence of malaria parasite infection was 32.1% among the participants. Out of that, 62.5% of patients with parasitaemia were symptomatic. Anaemia prevalence increased significantly with parasite density. MDA levels were significantly higher in patients with malaria symptoms than in those without symptoms. A significant and positive correlation was detected between MDA (r = 0.831, P &lt; 0.05), NO (r = 0.779, P &lt; 0.05), and malaria parasite density while, a significant and negative relationship occurred between parasite density and GSH (r = ?0.763, P &lt; 0.05) and Vit C (r = ?0.826, P &lt; 0.05) levels, SOD (r = ?0.621, P &lt; 0.05) and CAT (r = ?0.817, P &lt; 0.05) activities. The SOD activity and GSH level significantly decreased (P &lt; 0.05) with an increase in the MDA levels. These findings showed that MDA and nitric oxide levels increased both in malaria participants with or without symptoms. A similar decrease in the antioxidant defence system was observed in both symptomatic and asymptomatic patients. Therefore, there is a need to develop public health policies that encourage routine diagnosis and treatment of malaria in seemingly healthy people (asymptomatic cases), and this will play an essential role in controlling malaria in tropical countries. 
 
</p></abstract><kwd-group><kwd>Malaria</kwd><kwd> Asymptomatic</kwd><kwd> Symptomatic</kwd><kwd> Oxidative Stress</kwd><kwd> Antioxidant Defence System</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Globally, malaria poses an enormous threat to human life causing deaths worldwide. In 2020, an estimated 241 million cases of malaria occurred worldwide resulting in 627,000 deaths [<xref ref-type="bibr" rid="scirp.123109-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref2">2</xref>] . Plasmodium falciparum is the most prevalent and fatal malaria parasite species in Cameroon, and the disease continues to be a public health concern [<xref ref-type="bibr" rid="scirp.123109-ref3">3</xref>] . Falciparum malaria significantly affects children, and in areas where the disease is endemic, infections can be asymptomatic, uncomplicated or severe [<xref ref-type="bibr" rid="scirp.123109-ref4">4</xref>] .</p><p>Asymptomatic malaria has been described by WHO as the presence of asexual parasites in blood but without evidence of disease [<xref ref-type="bibr" rid="scirp.123109-ref5">5</xref>] . Other authors have described asymptomatic malaria as malaria parasitaemia of varying intensity, without fever or other acute symptoms, in people who have not recently received antimalarial treatment [<xref ref-type="bibr" rid="scirp.123109-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref6">6</xref>] . This form of malaria infection is prevalent in highly endemic areas of Africa and remains a challenge for malaria prevention and control strategies [<xref ref-type="bibr" rid="scirp.123109-ref7">7</xref>] . A recent study in Batoke and Buea conducted by Sumbele et al. [<xref ref-type="bibr" rid="scirp.123109-ref8">8</xref>] reported 36.4% malaria prevalence and a high asymptomatic malaria prevalence of 34.0% in children 15 years and below. It is still unknown why some malaria infections manifest no symptoms. According to some researchers, it may result from genetic diversity, parasite density, nutrient sequestration, and toxin production. Others contend that host-related elements such as immune system genes, lipid peroxidation, antioxidant markers, red blood cells (RBC) polymorphisms or abnormalities, circulating immunoglobulins and chemokines could be to blame [<xref ref-type="bibr" rid="scirp.123109-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref11">11</xref>] .</p><p>Prolonged and persistent malaria infections without symptoms are known to induce oxidative stress, which may result in adverse malaria outcomes and may lead to complications in the pathology of the disease [<xref ref-type="bibr" rid="scirp.123109-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref13">13</xref>] . Phagocytes (macrophages and neutrophils) are involved in the activation of the host’s natural defence mechanisms during malaria infection, which causes a significant rise in the level of reactive oxygen species and an imbalance between the production of oxidising species and the activity of antioxidant defence mechanisms. Oxidative stress is brought on by this imbalance [<xref ref-type="bibr" rid="scirp.123109-ref14">14</xref>] . In normal cells, there is an appropriate pro-oxidant/antioxidant balance. Shifting this equilibrium in favour of the pro-oxidant side causes oxidative stress, which is characterised by increased numbers of free radicals and increased lipid peroxidation of cell membranes, which causes devastating cell damage. Similarly, the parasite additionally stimulates specific cells in the development of reactive oxygen species (ROS) bringing about haemoglobin corruption. These ROS could be non-specific in nature, inducing lipid peroxidation and death of even non-infected RBCs [<xref ref-type="bibr" rid="scirp.123109-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref16">16</xref>] . More so, a decrease in antioxidant defence systems can be observed in such subjects, probably due to usage of erythrocytic antioxidants by parasites to counter the defence mechanism of patients [<xref ref-type="bibr" rid="scirp.123109-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref16">16</xref>] . Asymptomatic malaria infection may have a large effect on the delicate balance between the induction of antioxidant defense systems, oxidative stress and the level of GSH, SOD or CAT which determines the nature of the protective or pathogenic effects subsequently induced. Molecules such as GSH, SOD, CAT and ascorbic acid (Vit C), are part of the antioxidant compounds that prevent or reduce cell membrane damages [<xref ref-type="bibr" rid="scirp.123109-ref17">17</xref>] .</p><p>A study on the production of ROS and nitrogen species by Guha and colleagues [<xref ref-type="bibr" rid="scirp.123109-ref18">18</xref>] demonstrated the critical role that these compounds play in the emergence of systemic malarial sequelae [<xref ref-type="bibr" rid="scirp.123109-ref18">18</xref>] . Another research found that while CAT activity is lower in people with malaria than in people without the disease, oxidative stress markers such as MDA and NO levels are higher in people with malaria than in people without the disease [<xref ref-type="bibr" rid="scirp.123109-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref19">19</xref>] . Interestingly, Vit C possesses antioxidant properties and has been shown to scavenge free radicals [<xref ref-type="bibr" rid="scirp.123109-ref20">20</xref>] . Another study demonstrated that the physical and clinical conditions of asymptomatic malaria infected patients are not the same as those of symptomatic patients [<xref ref-type="bibr" rid="scirp.123109-ref21">21</xref>] . Finding techniques to combat the oxidative stress that comes along with the development of malaria from asymptomatic to symptomatic infection could be an important tool in achieving the malaria elimination goal.</p><p>Despite this state of knowledge, there is little information available regarding the degree of oxidative stress experienced by Cameroonian children suffering from Plasmodium falciparum infection with or without symptoms. Evidence for the involvement of oxidative stress makers and antioxidant defence systems among symptomatic and asymptomatic patients with malaria parasitaemia in the Mount Cameroon area is lacking. This lack of information models the background against which this study was aimed at, which is identifying the possible implications of oxidative stress and antioxidant defence systems in symptomatic and asymptomatic Plasmodium falciparum malaria infection among children aged 1 to 15 years in the Mount Cameroon area.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Description of the Study Area</title><p>The research was done in the Buea Regional Hospital, Fako Division, Cameroon, as well as in several of Buea Health District’s neighbourhoods, including Mile 18, Clerks’ Quarters, Bonduma, Great Soppo, Bokwango, Bova, Buea Town, Molyko, and Muea. Buea, which is situated on the south-eastern slope of Mount Cameroon is located between latitudes 3˚57'N - 4˚27'N and 8˚58'E - 9˚25'E, and is 500 - 4080 metres above sea level. Also, it has an average relative humidity of 80%, and an annual rainfall of 4000 mm. The research area experiences an equatorial climate, with temperatures ranging from 18˚C to 27˚C and two distinct seasons: a brief dry season (November to February) and a long rainy season (March to October). Anopheles gambiae is the primary malaria vector species, and Plasmodium falciparum accounts for nearly 90% of all cases of malaria that have been reported in this area [<xref ref-type="bibr" rid="scirp.123109-ref22">22</xref>] . The presence of Mount Cameroon in Buea makes it a popular tourist destination with a conducive economic environment. In Buea, the rainy season (March to September) is the peak period of malaria transmission [<xref ref-type="bibr" rid="scirp.123109-ref23">23</xref>] .</p></sec><sec id="s2_2"><title>2.2. Criteria for Selection of Study Population</title><p>Children aged 1 to 15 who lived in the study area and whose parents/guardians approved of their involvement in the study made up the study population. For this investigation, only febrile patients (temperature ≥ 37.5˚C), those with headache, chills (occurring every 2 - 4 days), loss of appetite, nausea, and vomiting (WHO, 2018) as well as individuals who appeared to be in good health were recruited. The study excluded patients with confirmed HIV status or more serious health conditions like diabetes or kidney disease. Additionally, those who had haematological diseases or had taken antimalarial medication two weeks before the study were not allowed to participate. Malaria was newly diagnosed in each subject.</p></sec><sec id="s2_3"><title>2.3. Study Design</title><p>The study was a cross-sectional investigation carried out from December 2019 to August 2021. At presentation to the hospital and in the communities, individuals were recruited after receiving administrative and ethical clearances following education. Informed consent/assent forms were given to parents/caregivers explaining the purpose, benefits, and risks of the study. Relevant demographic characteristics, malaria history and treatment, health-seeking behaviours, and symptoms shown were recorded with the aid of a structured questionnaire. Clinical evaluation was done by a trained physician, a clinical thermometer was used to obtain axillary temperature, and fever was considered to be a temperature equal to or above 37.5˚C. Blood samples were later collected for malaria parasite detection and full blood count (FBC) analyses.</p><p>The study used a practical multistage sampling strategy where distinct urban settings within the Buea Health Area were identified and chosen at random. Then, sample neighbourhoods in the chosen health areas were randomly selected. Potential participants in the chosen neighbourhoods were informed via the community relay agents, and on scheduled dates decided by the neighbourhood head, they were invited to a designated data collection hall. In the hospital, participants were prospectively enrolled upon presentation in the outpatient department as long as they met the study inclusion criteria.</p><p>The formula n  =  z<sup>2</sup>pq/d<sup>2</sup> (Bryan et al., 1996) was used to calculate the sample size for the study, where n was the necessary sample size, z was the requisite standard deviation for a 95 percent confidence interval (CI), and 33.8% represented the region’s malaria prevalence [<xref ref-type="bibr" rid="scirp.123109-ref23">23</xref>] . q was (1 − p), and d represented the 0.05 allowable error margin. 362 was the ideal number of participants. The sample size was raised to 473 to account for data loss from incorrect data entry.</p></sec><sec id="s2_4"><title>2.4. Sample Collection</title><p>While ensuring all procedures were sterile, 4 mL of venous blood was collected into dry and EDTA tubes. Labeled blood samples were transported on ice to the University of Buea, Life Science Laboratory for further analyses. As soon as the blood was dispensed into EDTA tubes, thin and thick blood films were made. Standard protocols were used to fix the thin films with absolute methanol; both blood films were stained for 15 minutes with 10% Giemsa stain, and then checked for the occurrence of malaria parasite and speciation [<xref ref-type="bibr" rid="scirp.123109-ref24">24</xref>] . If asexual/gametocyte forms were visible, the slides were considered positive and the parasitaemia was calculated as 200 white blood cells multiplied by the patient’s white blood cell (WBC) counts and stretched to 500 leukocytes if gametocytes were visible [<xref ref-type="bibr" rid="scirp.123109-ref24">24</xref>] . Per microliter (L) of blood, the parasite load was divided into four categories: low (1000 parasites), moderate (1000 - 4999 parasites), high (5000 - 99,999 parasites), and hyper (&gt;100,000 parasites) [<xref ref-type="bibr" rid="scirp.123109-ref25">25</xref>] . Aliquots of blood were kept at −20˚C until use after being centrifuged at 3000 rpm for 5 minutes in dry tubes.</p></sec><sec id="s2_5"><title>2.5. Determination of Haematological Parameters</title><p>To obtain values for haemoglobin (Hb), WBC, and platelets (Plt), a complete blood count was performed using the URIT 3300 haemoanalyser in accordance with the manufacturer’s instructions. According to WHO’s age-based categorization [<xref ref-type="bibr" rid="scirp.123109-ref26">26</xref>] , anaemia was defined as Hb  &lt;  11.0 g/L for children 1 - 5 years, Hb  &lt;  11.5 g/dL for children 6 - 11 years, and Hb  &lt;  12.0 g/dL for children 12 - 15 years old.</p></sec><sec id="s2_6"><title>2.6. Determination of Oxidative Stress Markers</title><sec id="s2_6_1"><title>2.6.1. Quantification of Malondialdehyde Concentration</title><p>MDA, defined as an indicator of lipid peroxidation, was evaluated in the serum of each participant. In fact, 500 &#181;L of serum was added in a tube containing 500 &#181;L of thiobarbituric acid solution (0.67%) and 250 &#181;L of trichloroacetic acid solution (20%). The mixture was incubated for 1-hour at 90˚C, and later cooled with tap water and the concentration of MDA was estimated spectrophotometrically as described by Liu et al. [<xref ref-type="bibr" rid="scirp.123109-ref27">27</xref>] .</p></sec><sec id="s2_6_2"><title>2.6.2. Measurement of Reduced Glutathione Concentration</title><p>The concentration of GSH was quantified spectrophotometrically in the serum of each participant using the method described by Ellman [<xref ref-type="bibr" rid="scirp.123109-ref28">28</xref>] . The sera were prepared following this previous protocol with Ellman’s reagent, and finally, the optical density of the mixture was determined at 412 nm. The level of GSH was expressed as &#181;g/g tissue.</p></sec><sec id="s2_6_3"><title>2.6.3. Determination of Superoxide Dismutase Activity</title><p>The activity of total SOD was measured as previously described by Sun et al. [<xref ref-type="bibr" rid="scirp.123109-ref29">29</xref>] . In a tube containing 134 &#181;L of serum, a volume of 1666 &#181;L of carbonate-bicarbonate Buffer (0.05 M; pH 10.2) and 200 &#181;L of adrenalin (0.3 mM) were added. Thereafter, the activity of SOD was estimated as the amount of enzyme that caused 50% inhibition of the nitroblue tetrazolium reduction rate. The mixture was homogenised and then the absorbance was read twice, after 20 and 80 seconds at 480 nm, using a spectrophotometer [<xref ref-type="bibr" rid="scirp.123109-ref30">30</xref>] .</p></sec><sec id="s2_6_4"><title>2.6.4. Quantification of Superoxide Catalase</title><p>The protocol described previously by Yadang et al. [<xref ref-type="bibr" rid="scirp.123109-ref31">31</xref>] was used in the determination of CAT activity in the serum of each participant. Briefly, in 125 &#181;L of serum, 125 &#181;L of phosphate buffer (0.1 M, pH 7.4) and 0.5 mL of hydrogen peroxide (30 mM H<sub>2</sub>O<sub>2</sub>) were added. Thereafter, the optical density of the mixture was read twice after 30-second, 60-second, and 90-second, at 240 nm using a spectrophotometer. The specific CAT activity was expressed as U/mg tissue.</p></sec><sec id="s2_6_5"><title>2.6.5. Measurements of Nitric Oxide Level</title><p>The total nitrite in the sample of each participant was quantified using the protocol described by [<xref ref-type="bibr" rid="scirp.123109-ref32">32</xref>] . The principle was the conversion of nitrate into nitrite by cadmium and followed by colour development with Griess reagent (0.1% N-naphthyl ethylene diamine and 1% sulfanilamide) in acidic medium (2.5%). In fact, Griess Reagent was used to convert nitrite into a purple-coloured azo compound in serum, which was then quantified by a spectrophotometer at 546 nm [<xref ref-type="bibr" rid="scirp.123109-ref33">33</xref>] .</p></sec><sec id="s2_6_6"><title>2.6.6. Determination of the Concentration of Vitamin C</title><p>The protocol described previously by Esaka et al. [<xref ref-type="bibr" rid="scirp.123109-ref34">34</xref>] was used to determine Vit C level in each sample. Vit C is reduced (ascorbic acid) and furthermore oxidised (dehydroascorbic acid). Briefly, in a 1 mL tube containing 5 &#181;L of serum, 300 &#181;L of chromogen reagent was added and incubated for 5 minutes at 37˚C. Thereafter, the enzyme reagent (ascorbic acid oxidase and peroxidase) was added to the mixture, vigorously shaken, and incubated at 37˚C for 5 minutes. Finally, the absorbance was read at 660 nm, twice at 30-second intervals, using a spectrophotometer and the concentration of total Vit C was expressed in mg/dL [<xref ref-type="bibr" rid="scirp.123109-ref35">35</xref>] .</p></sec></sec><sec id="s2_7"><title>2.7. Data Analysis</title><p>The collected data from this study was expressed as mean &#177; Standard Error of Mean; and analysed using Microsoft Excel 2016 and IBM-Statistical Package (SPSS, version 20). Means and standard deviations were used to describe continuous variables, whereas percentages were used to report categorical variables. The Student t-test was performed to compare the mean parasite density, the concentrations of MDA, GSH, NO, and Vit C, and the activities of CAT and SOD between symptomatic and asymptomatic malaria parasite-infected patients. Correlations were used to examine the associations between parasite density, oxidative stress, and antioxidant parameters. A model of linear regression was used to evaluate other variables that had a high and substantial correlation with parasite density. A P value &lt; 0.05 was considered statistically significant.</p></sec><sec id="s2_8"><title>2.8. Ethical Consideration</title><p>Regulatory approval was obtained from the Institutional Review Board, Faculty of Health Science, University of Buea (Ref No: 2019/811-05/UB/SG/IRB/FHS) as well as from the South West Regional Delegation of Public Health (R11/MINSANTE/SWR/RDPH/PS/295/943). The goal, dangers, and advantages of the study were thoroughly described to the parents/caregivers. Only kids whose parents agreed to their involvement in the study were enrolled. Data was managed with utmost confidentiality by assigning codes to the patients’ samples.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Baseline Characteristics of the Study Population</title><p><xref ref-type="table" rid="table1">Table 1</xref> indicates that a total of 473 participants were enrolled into the study, from which 195 (41.2%) were males and 278 (58.7%) were females. The mean (&#177;SEM) age in years was 6.8 &#177; 4.7 among which 268 (56.7%) were ≤ 5 years, while those in the 6-10 age group were 133 (28.1%) and those in the 11 – 15 age group were 72 (15.2%). Most (324, 68.5%) of the participants enrolled at presentation to the hospital had at least a secondary level of education 218 (46.1%) while 149 (31.5%) were enrolled in various neighbourhoods (Molyko, Government Reserve Area, Buea Town, Bokwango, Bokova, Great Soppo, Mile 18, Clerks quarters, Federal quarters and Bondum,) in the Buea community. Overall malaria prevalence in the study population was 32.1% (152) while symptomatic and asymptomatic malaria prevalence in the study population were respectively 62.5% (95) and 37.5% (57). More males were positive for malaria 59.9% (91) than females 40.1% (61). The highest malaria prevalence was seen in the 1 - 5 age group 47.4% (72) in which 45.6% (26) were asymptomatic followed by the 6 - 10 age group 28.3% (43) with 7.0% (4) being asymptomatic as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s3_2"><title>3.2. Clinical Characteristics of Study Participants</title><p>It can be depicted from <xref ref-type="table" rid="table2">Table 2</xref> that 136 (28.8%) febrile cases were recorded with a mean temperature of 37.9˚C &#177; 2.6˚C. The prevalence of anaemia in the study population was 62.1% (294) whereas the various prevalence of oxidative</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Baseline characteristics of the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Gender</th><th align="center" valign="middle"  colspan="3"  >Age group (years)</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >1 - 5</td><td align="center" valign="middle" >6 - 10</td><td align="center" valign="middle" >11 - 15</td></tr><tr><td align="center" valign="middle" >Participant % (n)</td><td align="center" valign="middle" >58.7 (278)</td><td align="center" valign="middle" >41.2 (195)</td><td align="center" valign="middle" >56.7 (268)</td><td align="center" valign="middle" >28.1 (133)</td><td align="center" valign="middle" >15.2 (72)</td><td align="center" valign="middle" >100 (473)</td></tr><tr><td align="center" valign="middle" >Mean age &#177; SEM (years)</td><td align="center" valign="middle" >7.3 &#177; 3.7</td><td align="center" valign="middle" >8.9 &#177; 4.2</td><td align="center" valign="middle" >2.7 &#177; 1.5</td><td align="center" valign="middle" >8.3 &#177; 1.5</td><td align="center" valign="middle" >13.3 &#177; 1.6</td><td align="center" valign="middle" >6.8 &#177; 4.7</td></tr><tr><td align="center" valign="middle" >Mean &#177; SEM Hb (g/dL)</td><td align="center" valign="middle" >10.6 &#177; 1.5</td><td align="center" valign="middle" >10.9 &#177; 1.4</td><td align="center" valign="middle" >10.6 &#177; 1.5</td><td align="center" valign="middle" >10.5 &#177; 1.8</td><td align="center" valign="middle" >11.2 &#177; 1.2</td><td align="center" valign="middle" >10.8 &#177; 1.4</td></tr><tr><td align="center" valign="middle" >Socio-demographic factors</td><td align="center" valign="middle"  colspan="6"  ></td></tr><tr><td align="center" valign="middle" >Point of presentation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Community (n)</td><td align="center" valign="middle" >64.4 (96)</td><td align="center" valign="middle" >35.6 (53)</td><td align="center" valign="middle" >49 (73)</td><td align="center" valign="middle" >28.2 (42)</td><td align="center" valign="middle" >22.8 (34)</td><td align="center" valign="middle" >31.5 (149)</td></tr><tr><td align="center" valign="middle" >Hospital (n)</td><td align="center" valign="middle" >56.2 (182)</td><td align="center" valign="middle" >43.8 (142)</td><td align="center" valign="middle" >60.2 (195)</td><td align="center" valign="middle" >28.1 (91)</td><td align="center" valign="middle" >11.7 (38)</td><td align="center" valign="middle" >68.5 (324)</td></tr><tr><td align="center" valign="middle" >Educational level of parent</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No formal/Primary (n)</td><td align="center" valign="middle" >63.2 (79)</td><td align="center" valign="middle" >36.8 (46)</td><td align="center" valign="middle" >57.6 (72)</td><td align="center" valign="middle" >32.0 (40)</td><td align="center" valign="middle" >10.4 (13)</td><td align="center" valign="middle" >26.4 (125)</td></tr><tr><td align="center" valign="middle" >Secondary (n)</td><td align="center" valign="middle" >51.4 (112)</td><td align="center" valign="middle" >48.6 (106)</td><td align="center" valign="middle" >65.1 (142)</td><td align="center" valign="middle" >23.4 (51)</td><td align="center" valign="middle" >11.5 (25)</td><td align="center" valign="middle" >46.1 (218)</td></tr><tr><td align="center" valign="middle" >Tertiary (n)</td><td align="center" valign="middle" >62.3 (81)</td><td align="center" valign="middle" >37.7 (49)</td><td align="center" valign="middle" >53.1 (69)</td><td align="center" valign="middle" >29.2 (38)</td><td align="center" valign="middle" >17.7 (23)</td><td align="center" valign="middle" >27.5 (130)</td></tr><tr><td align="center" valign="middle" >Malaria infection status</td><td align="center" valign="middle"  colspan="6"  ></td></tr><tr><td align="center" valign="middle" >Negative % (n)</td><td align="center" valign="middle" >64.8 (208)</td><td align="center" valign="middle" >35.2 (113)</td><td align="center" valign="middle" >58.9 (189)</td><td align="center" valign="middle" >18.7 (60)</td><td align="center" valign="middle" >22.4 (72)</td><td align="center" valign="middle" >67.9 (321)</td></tr><tr><td align="center" valign="middle" >Positive % (n)</td><td align="center" valign="middle" >40.1 (61)</td><td align="center" valign="middle" >59.9 (91)</td><td align="center" valign="middle" >47.4 (72)</td><td align="center" valign="middle" >28.3 (43)</td><td align="center" valign="middle" >24.3 (37)</td><td align="center" valign="middle" >32.1 (152)</td></tr><tr><td align="center" valign="middle" >Symptom status</td><td align="center" valign="middle"  colspan="6"  ></td></tr><tr><td align="center" valign="middle" >Asymptomatic % (n)</td><td align="center" valign="middle" >43.9 (25)</td><td align="center" valign="middle" >56.1 (32)</td><td align="center" valign="middle" >45.6 (26)</td><td align="center" valign="middle" >7.0 (4)</td><td align="center" valign="middle" >47.4 (27)</td><td align="center" valign="middle" >37.5 (57)</td></tr><tr><td align="center" valign="middle" >Symptomatic % (n)</td><td align="center" valign="middle" >37.9 (36)</td><td align="center" valign="middle" >62.1 (59)</td><td align="center" valign="middle" >48.4 (46)</td><td align="center" valign="middle" >41.1 (39)</td><td align="center" valign="middle" >10.5 (10)</td><td align="center" valign="middle" >62.5 (95)</td></tr></tbody></table></table-wrap><p>Hb: haemoglobin; SEM: Standard Error of Mean; n: number of participants.</p><p>stress parameters were as follows: MDA 83.5% (395), GSH 54.1% (256), CAT 45% (213), SOD 41.6 % (197), Vit C 35.3% (167) and NO 79.3% (375), respectively. Mean WBC and platelet count (SD) &#215; 10<sup>3</sup>/&#181;L were 69.0 (1007.4) and 223.0 (94.3) respectively while the geometric mean parasite density (SD) in parasites/&#181;L of blood was 577 (3240.9) as shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p></sec><sec id="s3_3"><title>3.3. Relationship between Malaria Parasite Infection and Mean Haemoglobin Level among the Study Participants</title><p>As shown in <xref ref-type="table" rid="table3">Table 3</xref>, study participants who tested positive for malaria parasitaemia had significantly lower mean Hb levels with respondents in the age group 1 - 5 years recording the lowest mean Hb levels (7.4 &#177; 1.3 g/dL) when compared with their counterparts who tested negative for malaria parasite infection (10.3 &#177; 1.1 g/dL) (P = 0.001). Interestingly, the mean Hb level was significantly lower (P = 0.001) in female participants who tested positive for the malaria parasite infection (7.5 &#177; 1.4 g/dL) when compared with those who tested negative (12.1 &#177; 1.6 g/dL). Equally, a significantly lower (P = 0.001) mean haemoglobin level was observed in males positive for malaria parasite infection (7.6 &#177; 1.5 g/dL) when compared with their contemporaries who were negative for infection (12.4 &#177; 1.2 g/dL).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical characteristics of the study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Category</th><th align="center" valign="middle" >% (n/N)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Fever status</td><td align="center" valign="middle" >Febrile</td><td align="center" valign="middle" >28.8 (136/473)</td></tr><tr><td align="center" valign="middle" >Afebrile</td><td align="center" valign="middle" >72.2 (337/473)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Anaemic status</td><td align="center" valign="middle" >Anaemic</td><td align="center" valign="middle" >62.1 (294/473)</td></tr><tr><td align="center" valign="middle" >Non-anaemic</td><td align="center" valign="middle" >37.8 (179/473)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Malaria parasite status</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >32.1 (152/473)</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >67.9 (321/473)</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Oxidative stress status</td><td align="center" valign="middle" >Malondialdehyde</td><td align="center" valign="middle" >83.5 (395/473)</td></tr><tr><td align="center" valign="middle" >Reduced glutathione</td><td align="center" valign="middle" >54.1 (256/473</td></tr><tr><td align="center" valign="middle" >Catalase</td><td align="center" valign="middle" >45.0 (213/473)</td></tr><tr><td align="center" valign="middle" >Super oxide dismutase</td><td align="center" valign="middle" >41.6 (197473)</td></tr><tr><td align="center" valign="middle" >Vitamin C</td><td align="center" valign="middle" >35.3 (167/473)</td></tr><tr><td align="center" valign="middle" >Nitrergic stress status</td><td align="center" valign="middle" >Nitric oxide</td><td align="center" valign="middle" >79.3 (375/473)</td></tr><tr><td align="center" valign="middle" >Mean temperature (SEM) in degree Celsius (˚C)</td><td align="center" valign="middle"  colspan="2"  >37.9 (2.6)</td></tr><tr><td align="center" valign="middle" >Mean Hb (SEM) in g/dL</td><td align="center" valign="middle"  colspan="2"  >10.4 (1.6)</td></tr><tr><td align="center" valign="middle" >Mean WBC (SEM) &#215; 10<sup>3</sup>/&#181;L</td><td align="center" valign="middle"  colspan="2"  >69.0 (1007.4)</td></tr><tr><td align="center" valign="middle" >Mean Platelets (SEM) &#215;10<sup>3</sup>/&#181;L</td><td align="center" valign="middle"  colspan="2"  >223.0 (94.3)</td></tr><tr><td align="center" valign="middle" >Geometric mean parasite density (SEM) in parasites /&#181;L of blood</td><td align="center" valign="middle"  colspan="2"  >577 (3240.9)</td></tr></tbody></table></table-wrap><p>Hb: haemoglobin; SEM: Standard Error of Mean; n: number of participants; N: total number of participants; WBC: white blood cells.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Relationship between malaria parasite infection and mean haemoglobin level</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  ></th><th align="center" valign="middle"  colspan="5"  >Haemoglobin, mean &#177; SEM (g/dL)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Gender</td><td align="center" valign="middle"  colspan="3"  >Age group (years)</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >1 - 5</td><td align="center" valign="middle" >6 - 10</td><td align="center" valign="middle" >11 - 15</td></tr><tr><td align="center" valign="middle" >Malaria infection status</td><td align="center" valign="middle"  colspan="5"  ></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >12.1 &#177; 1.6</td><td align="center" valign="middle" >12.4 &#177; 1.2</td><td align="center" valign="middle" >10.3 &#177; 1.1</td><td align="center" valign="middle" >10.4 &#177; 1.2</td><td align="center" valign="middle" >10.6 &#177; 1.3</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >7.5 &#177; 1.4</td><td align="center" valign="middle" >7.6 &#177; 1.5</td><td align="center" valign="middle" >7.4 &#177; 1.3</td><td align="center" valign="middle" >7.6 &#177; 1.2</td><td align="center" valign="middle" >7.8 &#177; 1.4</td></tr><tr><td align="center" valign="middle" >t values</td><td align="center" valign="middle" >1.542</td><td align="center" valign="middle" >2.152</td><td align="center" valign="middle" >2.825</td><td align="center" valign="middle" >2.954</td><td align="center" valign="middle" >2.603</td></tr><tr><td align="center" valign="middle" >P values</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Malaria symptom status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  ></td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >9.1 &#177; 1.5</td><td align="center" valign="middle" >9.0 &#177; 1.1</td><td align="center" valign="middle" >8.2 &#177; 1.1</td><td align="center" valign="middle" >8.4 &#177; 1.2</td><td align="center" valign="middle" >8.7 &#177; 1.3</td></tr><tr><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >7.4 &#177; 1.3</td><td align="center" valign="middle" >7.7 &#177; 1.1</td><td align="center" valign="middle" >7.2 &#177; 1.3</td><td align="center" valign="middle" >7.5 &#177; 1.2</td><td align="center" valign="middle" >7.7 &#177; 1.4</td></tr><tr><td align="center" valign="middle" >t values</td><td align="center" valign="middle" >−1.138</td><td align="center" valign="middle" >−1.273</td><td align="center" valign="middle" >−1.814</td><td align="center" valign="middle" >−1.143</td><td align="center" valign="middle" >−1.034</td></tr><tr><td align="center" valign="middle" >P values</td><td align="center" valign="middle" >0.212</td><td align="center" valign="middle" >0.103</td><td align="center" valign="middle" >0.192</td><td align="center" valign="middle" >0.152</td><td align="center" valign="middle" >0.251</td></tr></tbody></table></table-wrap><p>SEM: Standard Error of Mean.</p></sec><sec id="s3_4"><title>3.4. Effects of Malaria Parasite Infection on the Occurrence of Anaemia among the Study Participants</title><p>Student’s t-test analysis showed that there was a statistically significant difference among anaemic cases in age groups (<xref ref-type="table" rid="table4">Table 4</xref>). Children with malaria who were 1 to 5 years old had the highest anaemia prevalence (39.9%, P = 0.001) followed by those aged 6 - 10 years, where the prevalence was 30.8% (P = 0.001), and 11 to 15 years, where it was 38% (P = 0.001), respectively. From <xref ref-type="table" rid="table4">Table 4</xref>, it can be depicted that the prevalence of anaemia varied significantly (P &lt; 0.05) with the different age groups (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s3_5"><title>3.5. Relationship between Oxidative Stress Markers and Plasmodium falciparum Infection</title><p>The serum oxidant and antioxidant levels in children with malaria parasites are shown in <xref ref-type="table" rid="table5">Table 5</xref>. The concentrations of MDA and NO were significantly elevated (P = 0.001) in patients who tested positive for malaria parasite (0.52 &#177; 0.02 &#181;mol/L and 0.11 &#177; 0.02 mM) when compared with those who tested negative (0.37 &#177; 0.01 &#181;mol/L and 0.04 &#177; 0.01 mmol, respectively).</p><p>Meanwhile, the enzymatic activities of SOD and CAT were significantly lower (P &lt; 0.05) in malaria positive participants (0.78 &#177; 0.02 μmol/mL/min and 1.59 &#177; 0.24 μmol/mL/min respectively) when compared with those who were negative</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Effect of malaria parasite infection on the prevalence of anaemia among the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="4"  ></th><th align="center" valign="middle"  colspan="6"  >Anaemia status</th><th align="center" valign="middle"  colspan="2"   rowspan="4"  >Total</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Anaemic</td><td align="center" valign="middle"  colspan="3"  >Non anaemic</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Age group</td></tr><tr><td align="center" valign="middle" >1 - 5 (142)</td><td align="center" valign="middle" >6 - 10 (104)</td><td align="center" valign="middle" >11 - 15 (93)</td><td align="center" valign="middle" >1 - 5 (59)</td><td align="center" valign="middle" >6 - 10 (40)</td><td align="center" valign="middle" >11 - 15 (35)</td></tr><tr><td align="center" valign="middle"  colspan="8"  >Malaria infection status</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Negative % (n)</td><td align="center" valign="middle" >9.2 (14)</td><td align="center" valign="middle" >3.3 (5)</td><td align="center" valign="middle" >2.0 (3)</td><td align="center" valign="middle" >38.2 (58)</td><td align="center" valign="middle" >25.0 (38)</td><td align="center" valign="middle" >22.4 (34)</td><td align="center" valign="middle"  colspan="2"  >152</td></tr><tr><td align="center" valign="middle" >Positive % (n)</td><td align="center" valign="middle" >39.9 (128)</td><td align="center" valign="middle" >30.8 (99)</td><td align="center" valign="middle" >28.0 (90)</td><td align="center" valign="middle" >0.3 (1)</td><td align="center" valign="middle" >0.6 (2)</td><td align="center" valign="middle" >0.3 (1)</td><td align="center" valign="middle"  colspan="2"  >321</td></tr><tr><td align="center" valign="middle"  colspan="8"  >Total</td><td align="center" valign="middle" >473</td></tr><tr><td align="center" valign="middle" >t values</td><td align="center" valign="middle" >2.521</td><td align="center" valign="middle" >2.519</td><td align="center" valign="middle" >3.062</td><td align="center" valign="middle" >2.931</td><td align="center" valign="middle" >2.263</td><td align="center" valign="middle" >2.712</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >P values</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle"  colspan="8"  >Malaria parasite density</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Low (n)</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle"  colspan="2"  >133</td></tr><tr><td align="center" valign="middle" >Moderate (n)</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle"  colspan="2"  >109</td></tr><tr><td align="center" valign="middle" >High (n)</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle"  colspan="2"  >79</td></tr><tr><td align="center" valign="middle"  colspan="8"  >Total</td><td align="center" valign="middle" >321</td></tr><tr><td align="center" valign="middle" >t values</td><td align="center" valign="middle" >1.063</td><td align="center" valign="middle" >1.193</td><td align="center" valign="middle" >1.074</td><td align="center" valign="middle" >1.632</td><td align="center" valign="middle" >1.032</td><td align="center" valign="middle" >1.021</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >P values</td><td align="center" valign="middle" >0.012</td><td align="center" valign="middle" >0.027</td><td align="center" valign="middle" >0.042</td><td align="center" valign="middle" >0.027</td><td align="center" valign="middle" >0.043</td><td align="center" valign="middle" >0.027</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>n: number of participants.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Relationship between oxidative stress markers and Plasmodium falciparum infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Oxidative Stress marker</th><th align="center" valign="middle" >Malaria Infection Status</th><th align="center" valign="middle" >Mean &#177; SEM</th><th align="center" valign="middle" >t values</th><th align="center" valign="middle" >P values</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >MDA (&#181;mol/L)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0.37 &#177; 0.01</td><td align="center" valign="middle"  rowspan="2"  >−6.173</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0.52 &#177; 0.02</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GSH (&#181;g/mL)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0.12 &#177; 0.01</td><td align="center" valign="middle"  rowspan="2"  >−5.570</td><td align="center" valign="middle"  rowspan="2"  >0.002</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0.08 &#177; 0.01</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >SOD (μmol/mL/min)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >6.12 &#177; 0.21</td><td align="center" valign="middle"  rowspan="2"  >0.041</td><td align="center" valign="middle"  rowspan="2"  >0.021</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0.78 &#177; 0.02</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >CAT (μmol/mL/min)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >3.18 &#177; 1.02</td><td align="center" valign="middle"  rowspan="2"  >2.809</td><td align="center" valign="middle"  rowspan="2"  >0.029</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >1.59 &#177; 0.24</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Vit C (&#181;g/mL)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0.95 &#177; 0.07</td><td align="center" valign="middle"  rowspan="2"  >−4.187</td><td align="center" valign="middle"  rowspan="2"  >0.037</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0.41 &#177; 0.02</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >NO (mmol)</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >0.04 &#177; 0.01</td><td align="center" valign="middle"  rowspan="2"  >−3.048</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0.11 &#177; 0.02</td></tr></tbody></table></table-wrap><p>MDA: malondialdehyde; GSH: reduced glutathione; SOD: superoxide dismutase; CAT; catalase; Vit C: vitamin C; NO: nitric oxide.</p><p>(6.12 &#177; 0.21 μmol/mL/min and 3.18 &#177; 1.02 μmol/mL/min respectively) as seen in <xref ref-type="table" rid="table5">Table 5</xref>.</p><p>Furthermore, the mean serum level of Vit C was significantly lower (P = 0.001) in patients who tested positive for the malaria parasite (0.04 &#177; 0.01 mmol) when compared with those who tested negative (0.11 &#177; 0.02 mmol). The mean serum GSH level was significantly lower in patients with malaria parasite (0.08 &#177; 0.01 &#181;g/mL), whereas GSH was significantly higher (P &lt; 0.01) in malaria negative participants (0.12 &#177; 0.01 &#181;g/mL) (<xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s3_6"><title>3.6. Relationship between Oxidative Stress Parameters and Malaria Symptoms in Infected Participants</title><p>The mean concentration of MDA was raised significantly (P = 0.001) in participants who showed symptoms of malaria (0.97 &#177; 0.02 &#181;mol/L) when compared with those who were asymptomatic (0.61 &#177; 0.03 &#181;mol/L). Likewise, the average concentration of nitric oxide was also significantly higher among symptomatic patients (0.10 &#177; 0.01 mmol) when compared with asymptomatic participants (0.08 &#177; 0.01 mmol). The activities of the respective antioxidant parameters; SOD (0.59 &#177; 0.03 μmol/mL/min; P = 0.291) and CAT (1.18 &#177; 1.02 μmol/mL/min; P = 0.249) were reduced but not significantly in malaria parasite infected and symptomatic participants when compared with those who tested positive for malaria parasite and who were asymptomatic (SOD; 0.70 &#177; 0.02 μmol/mL/min; P = 0.291), (CAT; 1.45 &#177; 0.11 μmol/mL/min; P = 0.249). Furthermore, there was no significant difference (P = 0.227) in the mean concentration of Vit C among those with symptomatic (0.27 &#177; 0.02 &#181;g/mL) and asymptomatic (0.38 &#177; 0.03 &#181;g/mL) malaria (<xref ref-type="table" rid="table6">Table 6</xref>).</p></sec><sec id="s3_7"><title>3.7. Pearson Correlation Coefficient between Parasite Density, Lipid Peroxidation, Antioxidants, Nitric Oxide, and Vitamin C in Malaria Parasite-Infected Patients</title><p>Using the Pearson correlation coefficient, the relationship between parasite density, lipid peroxidation, antioxidants, NO, and Vit C in malaria parasite infected-patients were examined. A strong, positive and significant relationship existed between MDA (r = 0.831, P &lt; 0.05) and density of infection as well as NO (r = 0.779, P &lt; 0.05) and density of infection (<xref ref-type="table" rid="table7">Table 7</xref>). In addition, a negative and significant correlation existed between density of infection, SOD (r = −0.621, P &lt; 0.05), GSH (r = −0.763, P &lt; 0.05), CAT (r = −0.817, P &lt; 0.05) and Vit C (r = −0.826, P &lt; 0.05), in malaria parasite infected participants. However, the levels of SOD, GSH, CAT, and Vit C also lessened significantly (P &lt; 0.05) with an increase in MDA levels in malaria positive participants (<xref ref-type="table" rid="table7">Table 7</xref>).</p></sec><sec id="s3_8"><title>3.8. Relationship between the Mean Parasite Density versus Concentrations of Malondialdehyde, Nitric Oxide, Reduced Glutathione, Vitamin C, and the Activities of Catalase and Super Oxide Dismutase</title><p>There was a positive and significant correlation between mean parasite density</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Relationship between oxidative stress markers and malaria symptoms in infected patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Oxidative marker</th><th align="center" valign="middle" >Infection status</th><th align="center" valign="middle" >Mean &#177; SEM</th><th align="center" valign="middle" >t value</th><th align="center" valign="middle" >P value</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >MDA (&#181;mol/L)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >0.97 &#177; 0.02</td><td align="center" valign="middle"  rowspan="2"  >2.741</td><td align="center" valign="middle"  rowspan="2"  >0.001</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >0.61 &#177; 0.03</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GSH (&#181;g/mL)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >0.06 &#177; 0.01</td><td align="center" valign="middle"  rowspan="2"  >−2.019</td><td align="center" valign="middle"  rowspan="2"  >0.105</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >0.07 &#177; 0.01</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >SOD (μmol/mL/min)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >0.59 &#177; 0.03</td><td align="center" valign="middle"  rowspan="2"  >−1.964</td><td align="center" valign="middle"  rowspan="2"  >0.291</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >0.70 &#177; 0.02</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >CAT (μmol/mL/min)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >1.18 &#177; 1.02</td><td align="center" valign="middle"  rowspan="2"  >−0.593</td><td align="center" valign="middle"  rowspan="2"  >0.249</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >1.45 &#177; 0.11</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Vit C (&#181;g/mL)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >0.27 &#177; 0.02</td><td align="center" valign="middle"  rowspan="2"  >−4.187</td><td align="center" valign="middle"  rowspan="2"  >0.227</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >0.38 &#177; 0.03</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >NO (mmol)</td><td align="center" valign="middle" >Symptomatic</td><td align="center" valign="middle" >0.10 &#177; 0.01</td><td align="center" valign="middle"  rowspan="2"  >5.931</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >Asymptomatic</td><td align="center" valign="middle" >0.08 &#177; 0.01</td></tr></tbody></table></table-wrap><p>Symptomatic patients were those with signs such as headache, fever, stiffness, chills, loss of appetite, nausea, and vomiting according to WHO, 2013. MDA: malondialdehyde; GSH: reduced glutathione; SOD: superoxide dismutase; CAT; catalase; Vit C: vitamin C; NO: nitric oxide.</p><p>and the concentration of MDA (P &lt; 0.05) and the mean parasite density and the level of NO (P &lt; 0.05), respectively (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a) and <xref ref-type="fig" rid="fig1">Figure 1</xref>(b)). The regression equation showed that MDA equal to 7E−05 (density) + 0.2921 (R<sup>2</sup> = 0.7967) accounting for 79.67% of the variations observed in MDA with respect to parasite density. In addition, the regression equation for NO was 2E−0.5 (density) +</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Pearson’s correlation coefficient between parasite density, lipid peroxidation, antioxidants, nitric oxide, and vitamin C in malaria parasite infected-patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Density</th><th align="center" valign="middle" >MDA</th><th align="center" valign="middle" >GSH</th><th align="center" valign="middle" >SOD</th><th align="center" valign="middle" >CAT</th><th align="center" valign="middle" >Vit C</th><th align="center" valign="middle" >NO</th></tr></thead><tr><td align="center" valign="middle" >Density</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >MDA</td><td align="center" valign="middle" >0.831*</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >GSH</td><td align="center" valign="middle" >−0.763*</td><td align="center" valign="middle" >−0.418*</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >SOD</td><td align="center" valign="middle" >−0.621*</td><td align="center" valign="middle" >−0.472</td><td align="center" valign="middle" >0.594</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >CAT</td><td align="center" valign="middle" >−0.817*</td><td align="center" valign="middle" >−0.305</td><td align="center" valign="middle" >0.201</td><td align="center" valign="middle" >0.528</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Vit C</td><td align="center" valign="middle" >−0.826*</td><td align="center" valign="middle" >−0.169</td><td align="center" valign="middle" >0.283</td><td align="center" valign="middle" >0.339</td><td align="center" valign="middle" >0.624</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NO</td><td align="center" valign="middle" >0.779*</td><td align="center" valign="middle" >0.402*</td><td align="center" valign="middle" >−0.427</td><td align="center" valign="middle" >−0.701</td><td align="center" valign="middle" >−0.202</td><td align="center" valign="middle" >−0.521</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap><p>MDA: malondialdehyde; GSH: reduced glutathione; SOD: superoxide dismutase; CAT; catalase; Vit C: vitamin C; NO: nitric oxide. *P &lt; 0.05 statistically significant.</p><p>0.0249 (R<sup>2</sup> = 0.8198) accounting for 81.98% of the variations obtained in NO with respect to parasite density. Furthermore, a significant and inverse relationship existed between parasite density, GSH (P &lt; 0.05) and Vit C (P &lt; 0.05). The regression equation showed that GSH equal to −3E−05 (density) + 0.2724 (R<sup>2</sup> = 0.7844) accounting for 78.44% of the variations observed in GSH with respect to parasite density. It also showed in <xref ref-type="fig" rid="fig1">Figure 1</xref>(d) that Vit C equal to −6E−05 (density) + 0.752 (R<sup>2</sup> = 0.7552) accounting for 78% of the variations observed in Vit C values (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Furthermore, a significant, inverse, and strong relationship existed between malaria parasite density versus the activities of SOD (P &lt; 0.05) and CAT (P &lt; 0.05), respectively among the infected participant (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The regression equation showed that SOD activity equal to −5E−05 (density) + 0.8812 (R<sup>2</sup> = 0.6763) accounting for 66.93% of the variations recorded in the activity of SOD with respect to parasite density. On the other hand, the regression equation for CAT activity was −7E−05 (density) + 1.5452 (R<sup>2</sup> = 0.6145) accounting for 75.52% of the variations observed in CAT activity with respect to parasite density (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Oxidative stress contributes significantly in the pathogenesis of malaria and it can be demonstrated that Plasmodium falciparum infected red blood cells (RBC) produce ROS in infected patients. The increase in lipid peroxides as an indicator of oxidative stress in the organism has been documented as an ultimate toxic effect of raised reactive oxygen species production by the immune system of the body, as well as a synchronised release of oxygen radicals during haemoglobin degradation by malaria parasites [<xref ref-type="bibr" rid="scirp.123109-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref37">37</xref>] . This study investigated the implication of oxidative stress and antioxidant defence systems in symptomatic and asymptomatic Plasmodium falciparum malaria infection in children (1 to 15 years old) at presentation to the Regional Hospital, Buea and in some communities of the Mount Cameroon vicinity. The microscopically observed overall prevalence of malaria parasites (32.1%) is higher than the 27.7% reported by Sama et al. [<xref ref-type="bibr" rid="scirp.123109-ref38">38</xref>] . This indicates that malaria is still a threat in the Mount Cameroon vicinity. Despite increased control efforts, there is still a high incidence of malaria. This may be attributed to some factors like heavy rainfall, persistent humidity, and the neglect of asymptomatic cases of malaria, which serve as reservoirs for the parasite in this region.</p><p>Although malaria parasite-driven haemolysis contributes to a decrease in the concentration of haemoglobin in childhood malaria, one of the first pathways inducing the reduction of haemoglobin concentrations in children with malaria infection and anaemia, is impaired and/or ineffective erythropoiesis [<xref ref-type="bibr" rid="scirp.123109-ref39">39</xref>] , as well as overlapping features, including lysis of infected and uninfected RBC [<xref ref-type="bibr" rid="scirp.123109-ref40">40</xref>] , splenic sequestration of RBC [<xref ref-type="bibr" rid="scirp.123109-ref41">41</xref>] , dyserythropoiesis and bone marrow suppression [<xref ref-type="bibr" rid="scirp.123109-ref42">42</xref>] . The study findings showed that the prevalence of anaemia in the study population was 62.1% with the highest anaemia prevalence occurring in malaria positive (39.9%, P = 0.001) participants (1 - 5 years old). Out of that, these results could be justified by the elevated prevalence of malaria parasite in the Mount Cameroon vicinity. Malaria parasite infection has been reported severally as a risk factor of anaemia due to the degradation of haemoglobin during malaria infection [<xref ref-type="bibr" rid="scirp.123109-ref38">38</xref>] . In addition, some of the participants in this study were positive for malaria parasite infection but asymptomatic. Therefore, it can be suggested that Plasmodium malaria can be asymptomatic in positive participants as part of adaptation to survival. Being asymptomatic may result in infected participants not seeking treatment against malaria parasite infection [<xref ref-type="bibr" rid="scirp.123109-ref9">9</xref>] .</p><p>It can be depicted from the results of this study that anaemia was associated with malaria parasite infection of the peripheral blood in some of the participants. In fact, malaria can induce anaemia through the malaria parasitic damage of RBC and autoimmune reaction [<xref ref-type="bibr" rid="scirp.123109-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref44">44</xref>] . Additionally, there was an understandable increase in the prevalence anaemia with an increase in malaria parasite density followed by the occurrence of nitrosative and oxidative stresses. It has been previously well-known that in Plasmodium falciparum malaria infection, there is a significant relationship between an individual’s asexual erythrocytic-stage parasite density with the latency of presentation to a health care provider and the severity of clinical symptoms of the disease [<xref ref-type="bibr" rid="scirp.123109-ref45">45</xref>] . Oxidative stress is well known to induce anaemia through a sequence of processes. The principal target of oxidative stress is RBC due to their primary role as O<sub>2</sub>-carrying cells [<xref ref-type="bibr" rid="scirp.123109-ref46">46</xref>] . Oxidative stress-altered erythrocytes induce molecular signals that lead to the activation of the calcium ion-permeable cation channels, which enable calcium ions entry into the cells. This finally activates calcium ions-sensitive potassium ions channels thereby leading to cell shrinkage and scrambling of the erythrocyte membrane. Afterwards, phosphatidylserine gets exposed at the surface of the erythrocyte, distinctive signs of eryptosis (RBC impairment) leading to severe anaemia [<xref ref-type="bibr" rid="scirp.123109-ref46">46</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref47">47</xref>] . Surprisingly, there was no significant modification in the mean concentration of haemoglobin between symptomatic and asymptomatic malaria-infected patients. This finding further buttresses and justifies how dangerous asymptomatic malaria could be; although there are no apparent signs of malaria parasite infection, a lot of impairments would have been induced by the “hidden” parasite. Therefore, it is essential to understand the host-related factors that are responsible for this major setback.</p><p>As expected, the mean concentrations of MDA and nitric oxide were significantly higher among malaria parasite-infected patients compared to non-infected participants. This is a consequence that malaria patients had significantly reduced antioxidant defence system such as the mean concentration of GSH, and the activities of CAT and SOD than the non-infected participants. Oxidative stress is triggered by, respectively, the increase of reactive oxygen and/or nitrogen atoms that have unpaired electrons in their outer shell [<xref ref-type="bibr" rid="scirp.123109-ref48">48</xref>] . The oxidative stress markers (MDA and NO) recorded in this study were expansively higher in malaria parasite-infected patients than in the uninfected participants. This pathological development increases the oxidative stress index, as indicated in the results obtained, which is the ratio of total oxidative stress to total antioxidant activity and demonstrates the precise level of oxidative and antioxidant imbalance in infected patients [<xref ref-type="bibr" rid="scirp.123109-ref49">49</xref>] .</p><p>A compromised antioxidant defence system, alongside increased oxidative stress markers and eventually oxidative stress index values in malaria parasite infected-participants, might play an essential involvement in the induction of pathology, establishment and severity of malaria disease [<xref ref-type="bibr" rid="scirp.123109-ref49">49</xref>] . Studies have revealed that oxidative stress is frequent in malaria patients [<xref ref-type="bibr" rid="scirp.123109-ref47">47</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref50">50</xref>] as a result of the stimulation of the immune responses by the malaria parasite, in that way causing, respectively, the production of nitrogen atoms and/or reactive oxygen species [<xref ref-type="bibr" rid="scirp.123109-ref49">49</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref51">51</xref>] . An imbalance between free radicals and antioxidants in the system can lead to oxidative stress [<xref ref-type="bibr" rid="scirp.123109-ref52">52</xref>] . When free radicals are produced in amounts greater than the scavenging capacity of the endogenous antioxidant system, it brings about oxidative stress [<xref ref-type="bibr" rid="scirp.123109-ref53">53</xref>] . Malarial parasite infection is related to an increased production of reactive oxygen species by phagocytic cells. During Plasmodium blood stage infection, a relation between oxidative stress and inflammation is evidenced by reactive oxygen species-induced stimulation of macrophages. Alterations due to toxic metabolites of the host and parasite may render erythrocytes more exposed to impairment [<xref ref-type="bibr" rid="scirp.123109-ref54">54</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref55">55</xref>] .</p><p>Antioxidants are molecules which can combine with free radicals safely to stop the chain response before essential molecules are impaired. Excessive quantities of free radicals and oxidants can result in oxidative stress, a detrimental process that can dramatically affect wellbeing; and successively a variety of tissues, cellular elements, or components such as membrane lipids, proteins, lipoproteins, and deoxyribonucleic acid are all impacted [<xref ref-type="bibr" rid="scirp.123109-ref54">54</xref>] . Antioxidants such as GSH, SOD, and CAT are known to play a major function in the preservation and control of ROS levels during malaria parasite infection [<xref ref-type="bibr" rid="scirp.123109-ref56">56</xref>] . Hence, this may explain the variations in the level of oxidative stress and antioxidants in infected and uninfected respondents in this study. On the other hand, the antioxidant defence system and serum Vit C levels were significantly reduced among malaria parasite-infected patients compared to non-infected participants. This study shows that patients with malaria parasite infections had a significantly higher overall oxidative status than did healthy controls [<xref ref-type="bibr" rid="scirp.123109-ref49">49</xref>] . The fact that a significant and direct relationship occurred between parasite density and MDA, as well as NO, and an inverse relationship between parasite density and GSH supports the fact that malaria parasites are capable of inducing oxidative stress, and antioxidant levels (GSH) are equally reduced while combating the effects of oxidative stress [<xref ref-type="bibr" rid="scirp.123109-ref17">17</xref>] . This oxidised form of GSH reacts with free radicals and prevents the generation of most toxic hydroxyl radicals [<xref ref-type="bibr" rid="scirp.123109-ref17">17</xref>] . The decrease in GSH in malaria parasite-infected patients indicated that during infection, there was excessive oxidative stress and, as a consequence, glutathione concentrations were depleted while combating oxidative stress. The inverse relationship between parasite density and super oxide dismutase as well as CAT and Vit C may be suggesting the degradation of these antioxidants in fighting malaria-related oxidative stress [<xref ref-type="bibr" rid="scirp.123109-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref49">49</xref>] .</p><p>MDA (a biomarker of lipid peroxidation and a measure of oxidative stress) was increased among symptomatic malaria parasite infected patients when compared with those who were not symptomatic. Malaria pathogenesis and the severity of malaria-related complications could be significantly influenced by some factors such as anaemia and oxidative stress [<xref ref-type="bibr" rid="scirp.123109-ref57">57</xref>] [<xref ref-type="bibr" rid="scirp.123109-ref58">58</xref>] . Malaria stimulates the immune system of the body triggering the release of redox active by-products like superoxide, hydrogen peroxide, free heme hydroxyl radicals, lipid peroxides, and other related species [<xref ref-type="bibr" rid="scirp.123109-ref58">58</xref>] . A probable source of free radicals in malaria infection is the host’s haemoglobin degradation since the parasite utilises haemoglobin for its own nutrition, releasing a lot of circulating heme. These heme groups can provoke intravascular oxidative stress, inducing modifications in erythrocytes and endothelial cells and eventually favouring the entry of the parasite in tissues like the liver, spleen, heart, intestine and cerebrum [<xref ref-type="bibr" rid="scirp.123109-ref15">15</xref>] .</p><p>It can be depicted from the results obtained that there was no significant modification in the antioxidant defence system between symptomatic and asymptomatic malaria parasite infected-patients, suggesting that there is an equal amount of antioxidant responses to the parasite in both symptomatic and asymptomatic malaria parasite infected hosts. These results may explain in part why a patient will be symptomatic or asymptomatic, and concomitantly may suggest that the occurrence of oxidative stress as a result of malaria parasite infection may justify whether a patient will exhibit symptoms of malaria or not. However, there is a necessity for additional studies on factors that are responsible for malaria-related oxidative stress as well as asymptomatic malaria if the burden of malaria is to be controlled in Africa and other affected regions.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The estimated malaria parasite infection prevalence was 32.1% with the majority of the patients exhibiting parasitaemia being symptomatic. Malaria parasite infection of the peripheral blood was associated with anaemia and oxidative stress. Oxidative stress was associated with parasite density. Mean concentrations of MDA and NO were higher among malaria parasite-infected participants compared with non-infected group. A significant and direct relationship existed between parasite density and MDA as well as NO. In contrast, the antioxidant markers (GSH, SOD, CAT, and Vit C) did not change with whether a patient exhibited symptoms or not. However, oxidative stress parameters remained significantly linked to malaria with malaria symptoms in malaria parasite infected-participants. These findings imply that asymptomatic malaria is a serious obstacle to the malaria eradication strategy. Accordingly, there is a need for mechanistic studies, to explore the implication of oxidative stress in the pathogenesis of asymptomatic malaria and its complications, and to inform health policies that instigate routine diagnosis and therapy of Plasmodium malaria in supposedly healthy people if the malaria eradication goal is to be achieved in Africa.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors thank all participants who took part in the study. We are equally grateful to the authorities and clinicians in the various health facilities where this study was carried out for their support and cooperation.</p></sec><sec id="s7"><title>Authors’ Contributions</title><p>OAT, DDSF, GST, and HKK conceived and designed the study. OAT and VTJ conducted the research including data collection. OAT, DDSF, VTJ, and GST were responsible for data management and analysis. OAT interpreted the results and wrote the first draft of the manuscript. DDSF, GST, and HKK supervised and critically reviewed the manuscript for important and intellectual content. All authors read and approved the final manuscript.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Ojongnkpot, T.A., Sofeu-Feugaing, D.D., Jugha, V.T., Taiwe, G.S. and Kimbi, H.K. (2023) Implication of Oxidative Stress and Antioxidant Defence Systems in Symptomatic and Asymptomatic Plasmodium falciparum Malaria Infection among Children Aged 1 to 15 Years in the Mount Cameroon Area. Journal of Biosci- ences and Medicines, 11, 124-145. https://doi.org/10.4236/jbm.2023.112009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.123109-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Trottier, H. and Elliott, S.J. (2021) World Health Organization Recommends First Malaria Vaccine. Canadian Journal of Public Health, 112, 967-969. https://doi.org/10.17269/s41997-021-00593-6</mixed-citation></ref><ref id="scirp.123109-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2022) Malaria (Factsheet).</mixed-citation></ref><ref id="scirp.123109-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Teh, R.N., et al. (2018) Malaria Parasitaemia, Anaemia and Malnutrition in Children Less than 15 Years Residing in Different Altitudes along the Slope of Mount Cameroon: Prevalence, Intensity and Risk Factors. Malaria Journal, 17, Article No. 336. https://doi.org/10.1186/s12936-018-2492-1</mixed-citation></ref><ref id="scirp.123109-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Bousema, T., et al. (2016) The Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled Trial. PLoS Medicine, 13, e1001993. https://doi.org/10.1371/journal.pmed.1001993</mixed-citation></ref><ref id="scirp.123109-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2021) WHO Malaria Terminology. World Health Organization, Geneva.</mixed-citation></ref><ref id="scirp.123109-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lindblade, K.A., et al. (2013) The Silent Threat: Asymptomatic Parasitemia and Malaria Transmission. Expert Review of Anti-Infective Therapy, 11, 623-639. https://doi.org/10.1586/eri.13.45</mixed-citation></ref><ref id="scirp.123109-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, Y., et al. (2018) Risk Factors for Asymptomatic Malaria Infections from Seasonal Cross-Sectional Surveys along the China-Myanmar Border. Malaria Journal, 17, Article No. 247. https://doi.org/10.1186/s12936-018-2398-y</mixed-citation></ref><ref id="scirp.123109-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sumbele, I.U.N., et al. (2021) Asymptomatic and Sub-Microscopic Plasmodium falciparum Infection in Children in the Mount Cameroon Area: A Cross-Sectional Study on Altitudinal Influence, Haematological Parameters and Risk Factors. Malaria Journal, 20, Article No. 382. https://doi.org/10.1186/s12936-021-03916-7</mixed-citation></ref><ref id="scirp.123109-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Babalola, A.S., Jonathan, J. and Michael, B.E. (2020) Oxidative Stress and Anti-Oxidants in Asymptomatic Malaria-Positive Patients: A Hospital-Based Cross-Sectional Nigerian Study. The Egyptian Journal of Internal Medicine, 32, Article No. 23. https://doi.org/10.1186/s43162-020-00024-x</mixed-citation></ref><ref id="scirp.123109-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Mlugu, E.M., et al. (2020) Prevalence and Correlates of Asymptomatic Malaria and Anemia on First Antenatal Care Visit among Pregnant Women in Southeast, Tanzania. International Journal of Environmental Research and Public Health, 17, 3123. https://doi.org/10.3390/ijerph17093123</mixed-citation></ref><ref id="scirp.123109-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Shimizu, S., et al. (2020) Malaria Cross-Sectional Surveys Identified Asymptomatic Infections of Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi in Surat Thani, a Southern Province of Thailand. International Journal of Infectious Diseases, 96, 445-451. https://doi.org/10.1016/j.ijid.2020.05.022</mixed-citation></ref><ref id="scirp.123109-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ayala, A., Munoz, M.F. and Argüelles, S. (2014) Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity, 2014, Article ID: 360438. https://doi.org/10.1155/2014/360438</mixed-citation></ref><ref id="scirp.123109-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mills, M., et al. (2021) Malaria in Pregnancy: Considerations for Health Care Providers in Nonendemic Countries. Journal of Midwifery &amp; Women’s Health, 66, 343-350. https://doi.org/10.1111/jmwh.13258</mixed-citation></ref><ref id="scirp.123109-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Narsaria, N., et al. (2012) Oxidative Stress in Children with Severe Malaria. Journal of Tropical Pediatrics, 58, 147-150. https://doi.org/10.1093/tropej/fmr043</mixed-citation></ref><ref id="scirp.123109-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Percário, S., et al. (2012) Oxidative Stress in Malaria. International Journal of Molecular Sciences, 13, 16346-16372. https://doi.org/10.3390/ijms131216346</mixed-citation></ref><ref id="scirp.123109-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Das, B.S. and Nanda, N.K. (1999) Evidence for Erythrocyte Lipid Peroxidation in Acute Falciparum Malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 58-62. https://doi.org/10.1016/S0035-9203(99)90180-3</mixed-citation></ref><ref id="scirp.123109-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Megnekou, R., et al. (2015) Impact of Placental Plasmodium falciparum Malaria on the Profile of Some Oxidative Stress Biomarkers in Women Living in Yaoundé, Cameroon. PLOS ONE, 10, e0134633. https://doi.org/10.1371/journal.pone.0134633</mixed-citation></ref><ref id="scirp.123109-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Guha, M., et al. (2006) Apoptosis in Liver during Malaria: Role of Oxidative Stress and Implication of Mitochondrial Pathway. The FASEB Journal, 20, 1224-1226. https://doi.org/10.1096/fj.05-5338fje</mixed-citation></ref><ref id="scirp.123109-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sakyi, S.A., et al. (2012) Lipid Peroxidation and Catalase Levels among Children Presenting with Severe Falciparum Malaria in the Sefwi Wiawso Municipality, Ghana. Journal of Medical Sciences (Faisalabad), 12, 141-147. https://doi.org/10.3923/jms.2012.141.147</mixed-citation></ref><ref id="scirp.123109-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Osaro</surname><given-names> E. </given-names></name>,<etal>et al</etal>. (<year>2018</year>)<article-title>Serum Ascorbic Acid Levels among Children of African Descent with Acute Plasmodium falciparum Malaria in Sokoto, North Western Nigeria</article-title><source> SciFed Obstetrics &amp; Women Healthcare Journal</source><volume> 2</volume>,<fpage> 15</fpage>-<lpage>30</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.123109-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ogbodo, S., et al. (2014) Oxidative Stress in Symptomatic Malaria Parasitemic Pregnant Women from Malaria Endemic Area of Nigeria. The American Journal of the Medical Sciences, 4, 168-174.</mixed-citation></ref><ref id="scirp.123109-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ndamukong-Nyanga, J.L., et al. (2015) A Cross-Sectional Study on the Influence of Altitude and Urbanisation on Co-Infection of Malaria and Soil-Transmitted Helminths in Fako Division, South West Cameroon. International Journal of Tropical Disease and Health, 8, 150-164. https://doi.org/10.9734/IJTDH/2015/17926</mixed-citation></ref><ref id="scirp.123109-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Sumbele, I.U.N., et al. (2016) Malaria, Moderate to Severe Anaemia, and Malarial Anaemia in Children at Presentation to Hospital in the Mount Cameroon Area: A Cross-Sectional Study. Anemia, 2016, Article ID: 5725634. https://doi.org/10.1155/2016/5725634</mixed-citation></ref><ref id="scirp.123109-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Cheeseborough, R.K. (2009) Transforming Organizational Culture: Reinvigorating the Warrior Spirit. Army War College, Carlisle. https://doi.org/10.1037/e580452009-001</mixed-citation></ref><ref id="scirp.123109-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Sumbele, I.U., et al. (2014) Variation in Malariometric and Red Cell Indices in Children in the Mount Cameroon Area Following Enhanced Malaria Control Measures: Evidence from a Repeated Cross-Sectional Study. Malaria Journal, 13, Article No. 334. https://doi.org/10.1186/1475-2875-13-334</mixed-citation></ref><ref id="scirp.123109-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2001) Iron Deficiency Anemia. Assessment, Prevention, and Control. A Guide for Programme Managers. 47-62.</mixed-citation></ref><ref id="scirp.123109-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J., et al. (1990) Antioxidant Action of Guilingji in the Brain of Rats with FeCl3-Induced Epilepsy. Free Radical Biology and Medicine, 9, 451-454. https://doi.org/10.1016/0891-5849(90)90023-C</mixed-citation></ref><ref id="scirp.123109-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ellman, G.L. (1959) Tissue Sulfhydryl Groups. Archives of Biochemistry and Biophysics, 82, 70-77. https://doi.org/10.1016/0003-9861(59)90090-6</mixed-citation></ref><ref id="scirp.123109-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Sun, Y., Oberley, L.W. and Li, Y. (1988) A Simple Method for Clinical Assay of Superoxide Dismutase. Clinical Chemistry, 34, 497-500. https://doi.org/10.1093/clinchem/34.3.497</mixed-citation></ref><ref id="scirp.123109-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Misra, H.P. and Fridovich, I. (1972) The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase. Journal of Biological Chemistry, 247, 3170-3175. https://doi.org/10.1016/S0021-9258(19)45228-9</mixed-citation></ref><ref id="scirp.123109-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Fanta Yadang, S.A., et al. (2019) Quantification of Bioactive Compounds and Evaluation of the Antioxidant Activity of Carissa edulis Valh (Apocynaceae) Leaves. The Scientific World Journal, 2019, Article ID: 7549620. https://doi.org/10.1155/2019/7549620</mixed-citation></ref><ref id="scirp.123109-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Cortas, N.K. and Wakid, N.W. (1990) Determination of Inorganic Nitrate in Serum and Urine by a Kinetic Cadmium-Reduction Method. Clinical Chemistry, 36, 1440-1443. https://doi.org/10.1093/clinchem/36.8.1440</mixed-citation></ref><ref id="scirp.123109-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Miranda, K.M., Espey, M.G. and Wink, D.A. (2001) A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite. Nitric Oxide, 5, 62-71. https://doi.org/10.1006/niox.2000.0319</mixed-citation></ref><ref id="scirp.123109-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Esaka, M., Suzuki, K. and Kubota, K. (1985) Determination Method for L-Ascorbic Acid in Foods with Immobilized Ascorbate Oxidase. Agricultural and Biological Chemistry, 49, 2955-2960. https://doi.org/10.1080/00021369.1985.10867202</mixed-citation></ref><ref id="scirp.123109-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Cadenas, E. and Packer, L. (2002) Handbook of Antioxidants. Vol. 712, Marcel Dekker, New York.</mixed-citation></ref><ref id="scirp.123109-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Atiku, S.M., Louise, N. and Kasozi, D.M. (2019) Severe Oxidative Stress in Sickle Cell Disease Patients with Uncomplicated Plasmodium falciparum Malaria in Kampala, Uganda. BMC Infectious Diseases, 19, Article No. 600. https://doi.org/10.1186/s12879-019-4221-y</mixed-citation></ref><ref id="scirp.123109-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Tiyong Ifoue, S.H., et al. (2009) Evaluation of Oxidative Stress and Antioxidant Status of Pregnant Women Suffering from Malaria in Cameroon. Indian Journal of Clinical Biochemistry, 24, 288-293. https://doi.org/10.1007/s12291-009-0054-6</mixed-citation></ref><ref id="scirp.123109-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Sama, S.O., et al. (2021) Microcytic and Malarial Anaemia Prevalence in Urban Children ≤ 15 Years in the Mount Cameroon Area: A Cross-Sectional Study on Risk Factors. Anemia, 2021, Article ID: 5712309. https://doi.org/10.1155/2021/5712309</mixed-citation></ref><ref id="scirp.123109-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Grimes, C. and Fry, M. (2015) Nonregenerative Anemia: Mechanisms of Decreased or Ineffective Erythropoiesis. Veterinary Pathology, 52, 298-311. https://doi.org/10.1177/0300985814529315</mixed-citation></ref><ref id="scirp.123109-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Arora, G., et al. (2018) NK Cells Inhibit Plasmodium falciparum Growth in Red Blood Cells via Antibody-Dependent Cellular Cytotoxicity. Elife, 7, e36806. https://doi.org/10.7554/eLife.36806.017</mixed-citation></ref><ref id="scirp.123109-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Del Portillo, H.A., et al. (2012) The Role of the Spleen in Malaria. Cellular Microbiology, 14, 343-355. https://doi.org/10.1111/j.1462-5822.2011.01741.x</mixed-citation></ref><ref id="scirp.123109-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Wickramasinghe, S.N. and Abdalla, S.H. (2000) Blood and Bone Marrow Changes in Malaria. Best Practice &amp; Research Clinical Haematology, 13, 277-299. https://doi.org/10.1053/beha.1999.0072</mixed-citation></ref><ref id="scirp.123109-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Stoute, J.A., et al. (2003) Loss of Red Blood Cell-Complement Regulatory Proteins and Increased Levels of Circulating Immune Complexes Are Associated with Severe Malarial Anemia. The Journal of Infectious Diseases, 187, 522-525. https://doi.org/10.1086/367712</mixed-citation></ref><ref id="scirp.123109-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Buffet, P.A., et al. (2011) The Pathogenesis of Plasmodium falciparum Malaria in Humans: Insights from Splenic Physiology. Blood: The Journal of the American Society of Hematology, 117, 381-392. https://doi.org/10.1182/blood-2010-04-202911</mixed-citation></ref><ref id="scirp.123109-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">McElroy, P.D., et al. (1997) Dose- and Time-Dependent Relations between Infective Anopheles Inoculation and Outcomes of Plasmodium falciparum Parasitemia among Children in Western Kenya. American Journal of Epidemiology, 145, 945-956. https://doi.org/10.1093/oxfordjournals.aje.a009054</mixed-citation></ref><ref id="scirp.123109-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Bissinger, R., et al. (2019) Oxidative Stress, Eryptosis and Anemia: A Pivotal Mechanistic Nexus in Systemic Diseases. The FEBS Journal, 286, 826-854. https://doi.org/10.1111/febs.14606</mixed-citation></ref><ref id="scirp.123109-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Lang, K., et al. (2003) Cation Channels Trigger Apoptotic Death of Erythrocytes. Cell Death &amp; Differentiation, 10, 249-256. https://doi.org/10.1038/sj.cdd.4401144</mixed-citation></ref><ref id="scirp.123109-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Turrens, J.F. (2003) Mitochondrial Formation of Reactive Oxygen Species. The Journal of Physiology, 552, 335-344. https://doi.org/10.1113/jphysiol.2003.049478</mixed-citation></ref><ref id="scirp.123109-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Ebrahim, A., Gnanasekaran, N. and Genet, S. (2019) Oxidative Stress and Diminished Total Antioxidant Capacity in Malaria Patients Correspond to Increased Parasitemia and Severity of the Disease. ROS, 8, 287-296. https://doi.org/10.20455/ros.2019.855</mixed-citation></ref><ref id="scirp.123109-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Egwunyenga, A.O., Isamah, G. and Nmorsi, O.P. (2004) Lipid Peroxidation and Ascorbic Acid Levels in Nigeria Children with Acute Falciparum Malaria. African Journal of Biotechnology, 3, 560-563. https://doi.org/10.5897/AJB2004.000-2110</mixed-citation></ref><ref id="scirp.123109-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Kulkarni, A., et al. (2003) Studies on Biochemical Changes with Special Reference to Oxidant and Antioxidants in Malaria Patients. Indian Journal of Clinical Biochemistry, 18, 136-149. https://doi.org/10.1007/BF02867380</mixed-citation></ref><ref id="scirp.123109-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Pizzino, G., et al. (2017) Oxidative Stress: Harms and Benefits for Human Health. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 8416763. https://doi.org/10.1155/2017/8416763</mixed-citation></ref><ref id="scirp.123109-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Domej, W., Oettl, K. and Renner, W. (2014) Oxidative Stress and Free Radicals in COPD-Implications and Relevance for Treatment. International Journal of Chronic Obstructive Pulmonary Disease, 9, 1207-1224. https://doi.org/10.2147/COPD.S51226</mixed-citation></ref><ref id="scirp.123109-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Lobo, V., et al. (2010) Free Radicals, Antioxidants and Functional Foods: Impact on Human Health. Pharmacognosy Reviews, 4, 118-126. https://doi.org/10.4103/0973-7847.70902</mixed-citation></ref><ref id="scirp.123109-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Ty, M.C., et al. (2019) Malaria Inflammation by Xanthine Oxidase-Produced Reactive Oxygen Species. EMBO Molecular Medicine, 11, e9903. https://doi.org/10.15252/emmm.201809903</mixed-citation></ref><ref id="scirp.123109-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Akanbi, O., Odaibo, A. and Ademowo, O. (2009) Anti-MSP-119 Antibody (IgG) and Reactive Oxygen Species (ROS) Response against Malaria Infection in Pregnancy in South Western Nigeria. Asian Pacific Journal of Tropical Medicine, 2, 9-15.</mixed-citation></ref><ref id="scirp.123109-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Oyewole, I., et al. (2011) Epidemiology of Malaria and Insecticide Resistance Burden in Nigeria. Journal of Public Health and Epidemiology, 3, 6-12.</mixed-citation></ref><ref id="scirp.123109-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Sarr, D. (2017) Oxidative Stress: A Potential Therapeutic Target in Placental Malaria. Immunohorizons, 1, 29-41. https://doi.org/10.4049/immunohorizons.1700002</mixed-citation></ref></ref-list></back></article>